Apatinib combined with trastuzumab and albumin‑bound paclitaxel for treatment of HER2+ breast cancer with brain metastases resistant to anti‑HER2 TKIs: A case report
Affiliations: Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong 518116, P.R. China
- Published online on: December 20, 2022 https://doi.org/10.3892/ol.2022.13642
- Article Number: 56
Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.